By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enzo Life Sciences this week sued Abbott, Becton Dickinson, and Hologic claiming those companies infringe Enzo's patent covering a method of modifying nucleotides for use as probes.

In three separate lawsuits filed in the US District Court for the District of Delaware, Enzo alleges the companies infringe US Patent No. 6,992,180 titled "Oligo-or polynucleotides comprising phosphate-moiety labeled nucleotides," which was issued in January 2006 and assigned to Enzo.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.